Generex Biotechnology (OTCMKTS:GNBT) Trading Down 3.8%

Generex Biotechnology Co. (OTCMKTS:GNBT)’s share price fell 3.8% on Monday . The stock traded as low as $1.80 and last traded at $1.79. 42,191 shares were traded during trading, a decline of 24% from the average session volume of 55,547 shares. The stock had previously closed at $1.86.

The stock’s 50 day simple moving average is $1.25.

Generex Biotechnology (OTCMKTS:GNBT) last posted its earnings results on Monday, March 25th. The company reported ($0.16) earnings per share for the quarter. The company had revenue of $4.85 million for the quarter.

COPYRIGHT VIOLATION WARNING: This piece was reported by WKRB News and is owned by of WKRB News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.wkrb13.com/2019/06/17/generex-biotechnology-otcmktsgnbt-trading-down-3-8.html.

About Generex Biotechnology (OTCMKTS:GNBT)

Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity.

Featured Article: How does a 12b-1 fee affect fund performance?

Receive News & Ratings for Generex Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Generex Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.